PREVIEW MODE — Test page · Not connected to live forms
TRT Bangkok
Dr. Kenika reviewing daily Saxenda liraglutide titration plan at TRT Bangkok
Authentic Novo Nordisk · Daily Injection

Saxenda Thailand

Authentic Saxenda from Novo Nordisk — FDA-approved Liraglutide for chronic weight management. Daily subcutaneous injection. Cold-chain delivery across Thailand.

  • US FDA-approved · December 2014 · Chronic Weight Management
  • 8.0% body-weight reduction (SCALE Obesity & Prediabetes, 56 weeks)
  • Verifiable batch numbers · Pre-filled pen · 0.6 – 3 mg / DAY (daily injection)
Dr. Kenika consulting on Saxenda liraglutide therapy
Dr. Kenika, Medical Director
Medical Council of Thailand · Personal supervision
Authentic
Novo Nordisk Pen
Doctor-Led
Dr. Kenika · MD
Trusted
Verified 5.0
Cold-Chain
Pharmacy-Grade Delivery
Body-weight reduction · SCALE trial
8.0%
Mean body-weight reduction in the SCALE trial at 56 weeks on Saxenda (liraglutide) 3.0 mg daily.
Pi-Sunyer et al., NEJM 2015 · n=3,731 overweight adults
What that means for you

That's 6.8 kg — you'd weigh 78.2 kg.

Based on the 8.0% trial-mean. Individual outcomes vary.
Dr. Kenika explaining personalized GLP-1 weight-loss treatment plan on tablet during consultation at TRT BangkokDr. Kenika explaining daily Saxenda dosing scheduleSaxenda consultation room at TRT BangkokAuthentic Novo Nordisk Saxenda consultation at TRT Bangkok

Licensed medical facility · Real photos · Dr. Kenika

FDA Indication

Saxenda is the Obesity-Indication Brand

Saxenda is FDA-approved for chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) plus comorbidities. The molecule — Liraglutide — is a GLP-1 receptor agonist administered as a once-daily subcutaneous injection (in contrast to the weekly newer-generation drugs Wegovy and Ozempic). Saxenda was the first GLP-1 approved for obesity (December 2014) and remains an option for patients who prefer daily routines or have specific tolerability profiles.

How Saxenda Works

Liraglutide Molecule

GLP-1 receptor agonist. Single-pathway mechanism similar to Semaglutide but with shorter half-life requiring daily dosing. Established safety profile since 2014.

Read more about the molecule on our Liraglutide Thailand page.

Saxenda vs Wegovy

Same Molecule, Different Indication

Saxenda: Obesity indication (December 2014). Wegovy: Weekly injection · stronger weight loss. Both contain Liraglutide manufactured by Novo Nordisk. Dr. Kenika selects based on clinical situation.

See Wegovy Thailand.

Program Investment

Authentic Saxenda Program

Doctor-led · Authentic Novo Nordisk · Daily Liraglutide

from 600 ฿ per shot

Daily injection · same pen across all dose levels (0.6 → 3 mg titration)

Every program includes
Doctor consultation
Individualized dose plan
Ongoing monitoring
Cold-chain delivery

Saxenda (liraglutide) was the first FDA-approved GLP-1 for chronic weight management (2014). Daily injection, gradual five-week titration to 3 mg maintenance. Prescribed on patient request — most patients today choose the weekly options (Mounjaro or Wegovy) for stronger efficacy.

Your Personalized Trajectory

See your expected trajectory on Saxenda.

Trajectory based on the SCALE Obesity clinical-trial mean. Your individualized program is confirmed in consultation — this is an evidence-based estimate, not a guarantee.

kg
Saxenda

Your trajectory · based on SCALE Obesity mean (Saxenda)

Weeks to goal
Projected loss
Monthly investment
from 600 ฿/shot

Estimator uses peer-reviewed clinical-trial mean data. Individual outcomes vary based on adherence, baseline BMI, comorbidities, and lifestyle factors. Final program plan determined in private medical consultation.[ref]

Novo Nordisk Titration

Standard Saxenda Dose-Escalation

Saxenda follows the Novo Nordisk prescribing-information titration. Incremental dose increases minimize GI side effects.

View titration schedule
Week 1
0.6 mg daily
Adaptation. Sub-therapeutic dose.
Week 2
1.2 mg daily
Up-titration.
Week 3
1.8 mg daily
Continued escalation.
Week 4
2.4 mg daily
Pre-maintenance.
Week 5+
3 mg daily
Maintenance dose — SCALE Obesity efficacy reference[1].

Source: Novo Nordisk Saxenda prescribing information. Adapted individually by Dr. Kenika.

How It Works

A simple, medically supervised path to your Saxenda program.

1

Discovery Call

15-minute WhatsApp with our clinic team. Share your goals, history, and questions. No commitment.

2

Medical Evaluation

Dr. Kenika reviews your history. Labs ordered if needed. Treatment plan decided based on your specific clinical picture.

3

Start Treatment

First dose at clinic or cold-chain delivery to your address. Titration plan + side-effect support from day one.

4

Track & Adjust

Weekly check-ins during titration. Dose adjusted to your response. Sustainable maintenance plan together.

Why TRT Bangkok

Three foundations of our weight-loss program.

DOCTOR-LED CARE

Every Saxenda patient is personally supervised by Dr. Kenika — medical history review, HbA1c monitoring where relevant, dose decisions, titration adjustments. No intake-form-only approval.

100%
MANUFACTURER-DIRECT

Authentic Saxenda from Novo Nordisk via cold-chain pharmacy distribution. Batch numbers and expiry dates intact. No compounded substitutes, no grey-market sourcing.

Novo Nordisk
Your Doctor

Meet Your Medical Director

Dr. Kenika Norrachetdecha, MD — Medical Director at TRT Bangkok

Dr. Kenika Norrachetdecha, MD

Medical Director · TRT Bangkok

Hormone MedicineBrain HealthMetabolic OptimisationWeight Loss

Dr. Kenika Norrachetdecha, MD, leads TRT Bangkok's clinical practice. She specialises in hormone optimisation, regenerative medicine, and metabolic health, with advanced training under Dr. Mark Gordon (USA). Every Saxenda patient is personally supervised by Dr. Kenika.

3.000+

Patients Treated

500+

IV Treatments

3.000+

TRT Treatments

1.000+

GLP-1 Treatments

Dr. Kenika with Dr. Mark Gordon

International Training

Advanced training under Dr. Mark Gordon (USA) — featured on The Joe Rogan Experience.

Dr. Kenika Norrachetdecha with Dr. Mark Gordon at HEAT Conference

With Dr. Mark Gordon (USA)

HEAT Conference

Thai Medical License #72509 · Council Member #71253 — Verify ↗

Frequently Asked

Common Questions About Saxenda

Is this authentic Saxenda from Novo Nordisk?
Yes. Saxenda is manufactured by Novo Nordisk A/S. Each pen at TRT Bangkok ships through cold-chain pharmaceutical distribution with batch numbers and expiry dates intact. Verify manufacturer markings before your first injection.
Why daily injection instead of weekly?
Saxenda's active molecule Liraglutide has a shorter half-life than the newer Semaglutide or Tirzepatide. Daily dosing maintains steady drug levels. Some patients prefer daily routines; others move to weekly options like Wegovy or Zepbound for convenience.
How much weight will I lose on Saxenda?
In the SCALE Obesity & Prediabetes trial, adults on Saxenda 3 mg daily lost an average 8.0% of body weight over 56 weeks. This is less than the newer weekly agents (Wegovy 14.9%, Zepbound 20.9%). Individual results depend on starting BMI, adherence, and lifestyle support.
What are the side effects of Saxenda?
Most common: nausea, decreased appetite, mild GI discomfort during the dose-escalation period. These typically diminish over weeks. Slow titration starting at 0.6 mg daily minimizes effects.
How do I store Saxenda at home?
Refrigerator 2-8°C. Once in use, room temperature (below 30°C) for up to 30 days. Do not freeze. Avoid direct sunlight. In Thai climate, never leave the pen on a car dashboard or balcony.
Saxenda vs Wegovy — which is better?
Wegovy (weekly Semaglutide 2.4 mg) shows stronger weight loss than Saxenda (daily Liraglutide 3 mg) in head-to-head terms — 14.9% vs 8.0% average body-weight reduction. Choose Saxenda if you prefer a more established product, daily routines, or shorter half-life flexibility. Otherwise Wegovy is usually first-line. See Wegovy Thailand.
How does Saxenda pricing compare to weekly alternatives?
Saxenda US list price is approximately USD 1,349/month, often slightly more than monthly Wegovy. Thailand pricing meaningfully below US cash-pay rates. Some patients choose Saxenda for medical reasons; cost is rarely the deciding factor. Exact figure during consultation.
Patient Reviews

What patients say

5.0 / 5
15 verified Google Reviews

Real reviews from real patients on Google Business Profile. Currently 5.0 ★ from 15 verified reviews — and growing.

[Robert: paste actual Google Review quote — topic-filtered for this page]

[Robert: First name + initial]
[Robert: month year]

[Robert: paste actual Google Review quote — topic-filtered for this page]

[Robert: First name + initial]
[Robert: month year]

[Robert: paste actual Google Review quote — topic-filtered for this page]

[Robert: First name + initial]
[Robert: month year]

Read all reviews on Google Business Profile →

Ready to start Saxenda?

Request a consultation. Our clinic team responds within minutes on WhatsApp.

Dr. Kenika consulting on Saxenda liraglutide therapy
Medically reviewed by Dr. Kenika, Medical Director
Member, Medical Council of Thailand · Endocrinology & Metabolic Medicine
This page is reviewed for medical accuracy. Content is informational and does not substitute for individualized medical advice.

Sources

Peer-reviewed primary sources, FDA prescribing information, manufacturer documentation.

View all 4 sources
  1. Pi-Sunyer X, Astrup A, Fujioka K, et al. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management (SCALE). N Engl J Med. 2015;373(1):11-22. doi:10.1056/NEJMoa1411892. View on NEJM ↗
  2. U.S. FDA. Saxenda (liraglutide) injection prescribing information. Initial Approval: 2014. FDA label (PDF) ↗
  3. Wilding JPH et al. Once-Weekly Semaglutide (STEP-1). N Engl J Med. 2021;384(11):989-1002. View on NEJM ↗
  4. American Diabetes Association. Standards of Care in Diabetes 2024. View ↗

Additional clinical questions discussed during your private consultation with Dr. Kenika.

Related Pages

GLP-1 Programs
Locations
Resources
Other Services
Request consultation
Insights Library

Further reading

FOUNDATION · CLASS EXPLAINED
GLP-1 Medications Explained
STRONGER ALTERNATIVES
Mounjaro vs Wegovy